OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg
Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on Campus Flemingsberg. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.
Collecting High-Quality Target Cells – A Bottleneck
“Rapid access to high-quality cells can save lives,” says Jarmo Henriksson, CEO and the visionary founder of the newly established company OptiCell Solutions. Using advanced apheresis technology*, OptiCell Solutions enables the collection of cells from voluntary study participants, cell donors, and patients without delays.
“We aim to enhance access to new treatment options for patients with chronic diseases, offering our services to biotech companies, pharmaceutical companies, medical technology firms, CROs, and healthcare providers,” explains Jarmo Henriksson.
Flemingsberg – A Strategic Choice
OptiCell Solutions has chosen Flemingsberg as the base for its operations, a hub for innovation in Life Science and a growing ATMP cluster. Located near the Karolinska ATMP Center and Karolinska University Hospital, and within the flexible laboratory hotel Novum Labs, the company benefits from proximity to leading research and healthcare institutions.
“This geographical location supports the company’s vision of simplifying cell collection and accelerating the development of cell and gene therapies.”
Patient-Centered and Efficient Approach
OptiCell Solutions’ technology, called leukapheresis, enables the gentle and efficient collection of necessary cells. This method can yield at least 20 times more target cells compared to standard blood donations, while returning the blood to the donor for increased safety.
“At OptiCell Solutions, we prioritize creating a safe and comfortable environment for cell donors. With our apheresis technology, bright facilities, and comfortable treatment chairs, we ensure high-quality cell materials while providing a positive experience for donors,” says Jarmo Henriksson.
What Are Your Future Goals?
“OptiCell Solutions’ long-term goal is to become a leading player in cell collection for cell and gene therapies. We see great potential in Flemingsberg as a future center for innovation and collaboration within Life Science,” says Jarmo.
Finally, Jarmo shares that OptiCell Solutions also envisions supporting the development of precision medicine by ensuring access to high-quality target cells across Europe, a crucial factor for the success of biological drugs and innovative treatments.
*Apheresis technology involves separating blood into its components using centrifugation during ongoing leukapheresis.
Career: Jarmo is the CEO and one of the founders of OptiCell Solutions. He is a licensed specialist nurse, as well as the founder and owner of OptiCell Solutions AB. He has 30 years of clinical experience at Karolinska University Hospital in the field of cell and organ transplantation, where he has served as the head of the Apheresis Unit for the past nine years.
Hobbies: “I enjoy working out at the gym, gardening, and spending time with family and friends.”
Are you just starting out and looking for an innovative environment with state-of-the-art lab spaces and room for growth? Welcome to Novum Labs, a cutting-edge coworking concept where research and development take center stage.
Here we offer:
– Modern and bright laboratory and office spaces
– Access to meeting rooms and communal areas such as the cafeteria and locker rooms
– Lab services
– Cleaning services
– Tailored lease agreements for life science operations
OptiCell Solutions – A Key Player in Cell and Gene Therapy Establishes in Flemingsberg
Flemingsberg continues to be a natural choice for knowledge-intensive and innovative businesses. OptiCell Solutions is a company that recently launched its operations at Novum Labs on Campus Flemingsberg. Founded in 2024 by specialists from Karolinska University Hospital and entrepreneurs from the Life Science industry, the company specializes in improving the availability of high-quality target cells for cell and gene therapies, a critical component of the growing ATMP (Advanced Therapy Medicinal Products) sector.
A Groundbreaking for 800 New Student and Research Apartments at Campus Flemingsberg
Today, the first groundbreaking was held for Byggvesta and EQT Exeter's 800 new student and research apartments right in the knowledge-intensive Campus Flemingsberg, with the business community just outside the door.
Welcoming more culture and creative industries to a growing place
On August 29, the Royal Swedish Opera and the Swedish National Dramatic Theatre opened their new studios in Flemingsberg with a festive mix of song, poetry and inspiring conversations about collaboration. The opening marks an important milestone in Flemingsberg's development and brings us one step closer to the vision of creating a place where knowledge and creativity meet in southern Stockholm.
Campus Day 2024: A Meeting Place for Students and Researchers at Campus Flemingsberg
Every year, Campus Day is held at Campus Flemingsberg – a place where five colleges and universities gather to get to know each other better, enjoy music, listen to rectors' speeches and take part in important information.
TAKE YOUR IDEA TO THE NEXT LEVEL: Flemingsberg Science Award IDEA 2024 is now open for registration
It’s finally time for the annual competition Flemingsberg Science Award IDEA. The goal is to attract innovators from Flemingsberg, helping them take the step towards realizing their visions while also participating in shaping the businesses of the future. Do you have an idea that can contribute to a better world? Then you should take part in the Flemingsberg Science Award competition.
